|
|
FDA Approved, HIV Confirmatory Test
Sanochemia's Fluorognost IFA™ HIV-1 is the result of dedicated research and development since 1985. The US Food and Drug Administration (FDA) approved the assay in February 1992. You may have previously known us as Waldheim IFA Fluorognost IFA confirmatory test for HIV-1 allows laboratories to establish a definite status for samples that are positive or indeterminate in routine screening assays or newer rapid tests as a PRIMARY CONFIRMATION TEST for HIV-1 in lieu of western blot. Serum, plasma and dried blood spot (DBS) eluates are all suitable substrates for testing. The assay is completed in 90 minutes, requires minimal amounts of sample, and provides an extremely high degree of accuracy. Fluorognost HIV-1 IFA is currently being used by many Public Health Laboratories, Blood Banks, Commercial Reference Laboratories and other labs performing HIV-1 testing in the US and Europe.
HIV-2 What is your lab's interest in confirmation? Fluorognost HIV-1 IFA Training Seminar CDC Webcast on new RAPID HIV Tests - Must Confirm! Fluorognost Poster from APHL Mtg March 2003 Package inserts and technical information on Fluorognost HIV-1 |
